Medical Grade Face Shield Articles & Analysis
6 news found
Boston: “According to the latest BCC Research study, the demand for EMI/RFI: Materials and Technologies is estimated to increase from $7.4 billion in 2023 to reach $9.2 billion by 2028, at a compound annual growth rate (CAGR) of 4.6% from 2023 through 2028.” This comprehensive report delves into the dynamic landscape of the EMI/RFI materials and technologies market, meticulously ...
Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund. This funding will support Synaptive Medical’s $2.8 million project to expand manufacturing and research and development activities related to the company’s head-only Magnetic Resonance Imaging (MRI) system. The Synaptive MRI is a 0.5T system that was designed to overcome ...
As a sponsor of the award, eg have offered a total of 10 days’ worth of engineering expertise, shared amongst the winning three applicants, that can be used towards the realisation of their innovation. The first prize was awarded to Leuko, who will receive five days’ worth of engineering and development support with the eg technology engineering specialists. Leuko have created ...
GALWAY, Ireland–Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced Food and Drug Administration (FDA) clearance of its proprietary NEUROMARK™ Rhinitis Neurolysis Therapy™ (RNT). The clearance gives clinicians access to an in-office treatment designed to create lesions to disrupt the posterior nasal nerves, ...
Ahlstrom-Munksjö announces the launch of TrustShield™ Biological, a personal protective apparel medical fabric designed to shield against hazardous pathogens. The TrustShield product portfolio offers a range of medical fabrics designed to provide superior protection in the operating room, clinical and laboratory environments. ...
ByAhlstrom
An Irish company developing a breakthrough therapy for a common nasal condition has raised €9.3 million. Neurent Medical, based in Oranmore, Co Galway, is developing a medical device that would allow doctors treat patients with rhinitis in their offices, rather than in a surgical setting. The funding round was led by Fountain Healthcare Partners, the Irish life sciences fund. Others ...
